其他
Pliant Therapeutics(PLRX)08-14 20:55
$Pliant Therapeutics(PLRX)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001172661-25-003267 Act: 34 Size: 11 KB 网页链接
简介：Pliant Therapeutics, Inc.于2015年6月根据特拉华州法律注册成立。该公司是一家临床阶段生物制药公司，致力于发现和开发用于治疗纤维化的新疗法。他们最初的重点是通过抑制整合素介导的TGF-β活化来治疗纤维化。该公司利用他们对纤维化生物学的深刻理解，以及他们在药物化学和转化医学方面的专业知识，开发了一套专有工具，旨在快速有效地发现和降低候选产品的风险。他们的全资主要候选药物PLN-74809是整合素的口服小分子双重选择性抑制剂，该公司正在开发该药物用于治疗特发性肺纤维化或IPF，原发性硬化性胆管炎或PSC。
| 今开：1.51 | 昨收：1.53 |
| 最高：1.62 | 最低：1.45 |
| 涨停价： | 跌停价： |
| 总市值：98319016 |
Pliant Therapeutics(PLRX)08-14 20:55
$Pliant Therapeutics(PLRX)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001172661-25-003267 Act: 34 Size: 11 KB 网页链接
Pliant Therapeutics(PLRX)11-07 05:25
$Pliant Therapeutics(PLRX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001746473-25-000175 Act: 34 Size: 6 MB 网页链接
Pliant Therapeutics(PLRX)09-05 05:15
$Pliant Therapeutics(PLRX)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0000902664-25-003977 Act: 34 Size: 17 KB 网页链接
Pliant Therapeutics(PLRX)11-07 05:15
$Pliant Therapeutics(PLRX)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001746473-25-000173 Act: 34 Size: 285 KB 网页链接
Pliant Therapeutics(PLRX)10-25 04:35
$Pliant Therapeutics(PLRX)$ 8-K Current report, item 5.02 Accession Number: 0001746473-25-000159 Act: 34 Size: 190 KB 网页链接
Pliant Therapeutics(PLRX)10-21 05:35
$Pliant Therapeutics(PLRX)$ 8-K Current report, item 1.02 Accession Number: 0001193125-25-243619 Act: 34 Size: 173 KB 网页链接
Pliant Therapeutics(PLRX)11-07 05:25
$Pliant Therapeutics(PLRX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001746473-25-000175 Act: 34 Size: 6 MB 网页链接查看全文
Pliant Therapeutics(PLRX)11-07 05:15
$Pliant Therapeutics(PLRX)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001746473-25-000173 Act: 34 Size: 285 KB 网页链接查看全文
Pliant Therapeutics(PLRX)10-25 04:35
$Pliant Therapeutics(PLRX)$ 8-K Current report, item 5.02 Accession Number: 0001746473-25-000159 Act: 34 Size: 190 KB 网页链接查看全文
Pliant Therapeutics(PLRX)10-21 05:35
$Pliant Therapeutics(PLRX)$ 8-K Current report, item 1.02 Accession Number: 0001193125-25-243619 Act: 34 Size: 173 KB 网页链接查看全文
Pliant Therapeutics(PLRX)09-05 05:15
$Pliant Therapeutics(PLRX)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0000902664-25-003977 Act: 34 Size: 17 KB 网页链接查看全文
Pliant Therapeutics(PLRX)08-14 20:55
$Pliant Therapeutics(PLRX)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001172661-25-003267 Act: 34 Size: 11 KB 网页链接查看全文
Pliant Therapeutics(PLRX)08-08 04:25
$Pliant Therapeutics(PLRX)$ 8-K Current report, item 9.01 Accession Number: 0001746473-25-000149 Act: 34 Size: 286 KB 网页链接查看全文
Pliant Therapeutics(PLRX)08-08 04:25
$Pliant Therapeutics(PLRX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001746473-25-000150 Act: 34 Size: 6 MB 网页链接查看全文
Pliant Therapeutics(PLRX)08-07 02:15
$Pliant Therapeutics(PLRX)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0000895421-25-000462 Act: 34 Size: 7 KB 网页链接查看全文
Pliant Therapeutics(PLRX)07-30 02:25
$Pliant Therapeutics(PLRX)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0000932471-25-000999 Act: 34 Size: 6 KB 网页链接查看全文
$Pliant Therapeutics(PLRX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001746473-25-000175 Act: 34 Size: 6 MB 网页链接
$Pliant Therapeutics(PLRX)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001746473-25-000173 Act: 34 Size: 285 KB 网页链接
$Pliant Therapeutics(PLRX)$ 8-K Current report, item 5.02 Accession Number: 0001746473-25-000159 Act: 34 Size: 190 KB 网页链接
$Pliant Therapeutics(PLRX)$ 8-K Current report, item 1.02 Accession Number: 0001193125-25-243619 Act: 34 Size: 173 KB 网页链接
$Pliant Therapeutics(PLRX)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0000902664-25-003977 Act: 34 Size: 17 KB 网页链接
$Pliant Therapeutics(PLRX)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001172661-25-003267 Act: 34 Size: 11 KB 网页链接
$Pliant Therapeutics(PLRX)$ 8-K Current report, item 9.01 Accession Number: 0001746473-25-000149 Act: 34 Size: 286 KB 网页链接
$Pliant Therapeutics(PLRX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001746473-25-000150 Act: 34 Size: 6 MB 网页链接
$Pliant Therapeutics(PLRX)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0000895421-25-000462 Act: 34 Size: 7 KB 网页链接
$Pliant Therapeutics(PLRX)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0000932471-25-000999 Act: 34 Size: 6 KB 网页链接